欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0787/001
药品名称
Rivastigmina Aurobindo
活性成分
rivastigmine tartrate 1.5 mg
剂型
Capsule, hard
上市许可持有人
Aurobindo Pharma (Portugal), Unip. Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Rivastigmine Aurobindo 1,5 mg Hartkapseln
France (FR)
Malta (MT)
Rivastigmine Aurobindo 1,5mg Capsules, Hard
许可日期
2012/10/18
最近更新日期
2024/07/22
药物ATC编码
N06DA03 rivastigmine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
Clean_LAB_Rivastigmine Aurobindo
Date of last change:2024/09/06
Final Product Information
|
Clean_Lab_Rivastigmine Glob
Date of last change:2024/09/06
Final Product Information
|
Clean_PIL_Rivastigmine Aurobindo
Date of last change:2024/09/06
Final Product Information
|
Clean_PIL_Rivastigmine Glob
Date of last change:2024/09/06
Final Product Information
|
Clean_SPC_Rivastigmine Aurobindo
Date of last change:2024/09/06
Final Product Information
|
Clean_SPC_Rivastigmine Glob
Date of last change:2024/09/06
Final PL
|
common_pl
Date of last change:2024/09/06
Final SPC
|
common_spc
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase